Towards understanding the neuronal ceroid lipofuscinoses

被引：57

作者：

Kohlschuetter, Alfried ^{[1
]}

Schulz, Angela ^{[1
]}

机构：

[1] Univ Med Ctr Eppendorf, Childrens Hosp, Hamburg, Germany

来源：

BRAIN & DEVELOPMENT | 2009年 / 31卷 / 07期

关键词：

Dementia; Retinopathy; Lysosomal storage disorder; Neurodegeneration; CATHEPSIN-D DEFICIENCY; PROTEIN; DISEASE; MUTATION; GENE;

D O I：

10.1016/j.braindev.2008.12.008

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

The neuronal ceroid lipofuscinoses (NCLs) are a group of genetic progressive brain diseases of children and Young adults, characterized by a decline of mental and other capacities, epilepsy, and visual loss through retinal degeneration. The common pathology of NCLs is that of a storage disorder with accumulation of an autofluorescent material, ceroid lipofuscin, in combination with the degeneration of neuronal cells. At least 10 genetically distinct NCLs, designated CLN1 to CLN10, are presently known. Several NCLs exhibit a widely variable clinical picture, depending on the severity of the individual Mutation. Some NCLs are not particularly rare. With increasing awareness of these disorders and better diagnostic techniques available, the number of recognized patients is rising. This overview briefly summarizes recent developments (or quotes corresponding literature) that are important to understand, diagnose, and manage patients suffering from one of these incurable disorders. (C) 2008 Elsevier B.V. All rights reserved.

引用

页码：499 / 502

页数：4

共 20 条

[1] Intermittent prednisolone and autoantibodies to GAD65 in juvenile neuronal ceroid lipofuscinosis [J].

Aberg, L. ;

Talling, M. ;

Harkonen, T. ;

Lonnqvist, T. ;

Knip, M. ;

Alen, R. ;

Rantala, H. ;

Tyynela, J. .

NEUROLOGY, 2008, 70 (14) :1218-1220

[2] Revelation of a novel CLN5 mutation in early juvenile neuronal ceroid lipofuscinosis [J].

Cannelli, N. ;

Narclocci, N. ;

Cassandrini, D. ;

Morbin, M. ;

Aiello, C. ;

Bugiani, M. ;

Criscuolo, L. ;

Zara, F. ;

Striano, P. ;

Granata, T. ;

Bertini, E. ;

Simonati, A. ;

Santorelli, F. M. .

NEUROPEDIATRICS, 2007, 38 (01) :46-49

[3] Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis [J].

Chang, Michael ;

Cooper, Jonathan D. ;

Sleat, David E. ;

Cheng, Seng H. ;

Dodge, James C. ;

Passini, Marco A. ;

Lobel, Peter ;

Davidson, Beverly L. .

MOLECULAR THERAPY, 2008, 16 (04) :649-656

[4] Cellular therapy for childhood neurodegenerative disease. Part I: rationale and preclinical studies [J].

Guillaume, Daniel J. ;

Huhn, Stephen L. ;

Selden, Nathan R. ;

Steiner, Robert D. .

NEUROSURGICAL FOCUS, 2008, 24 (3-4)

[5]

Hofmann S.L., 2001, The Metabolic and Molecular Basis of Inherited Disease, P3877

[6]

JALANKO A, BBA MOL CEL IN PRESS, DOI DOI 10.1016/J.BBAMCR-.2008.11.004

[7] A function retained by the common mutant CLN3 protein is responsible for the late onset of juvenile neuronal ceroid lipofuscinosis [J].

Kitzmueller, Claudia ;

Haines, Rebecca L. ;

Codlin, Sandra ;

Cutler, Daniel F. ;

Mole, Sara E. .

HUMAN MOLECULAR GENETICS, 2008, 17 (02) :303-312

[8] Inefficient cleavage of palmitoyl-protein thioesterase (PPT) substrates by aminothiols: Implications for treatment of infantile neuronal ceroid lipofuscinosis [J].

Lu, JY ;

Hofmann, SL .

JOURNAL OF INHERITED METABOLIC DISEASE, 2006, 29 (01) :119-126

[9] A clinical rating scale for Batten disease - Reliable and relevant for clinical trials [J].

Marshall, FJ ;

de Blieck, A ;

Mink, JW ;

Dure, L ;

Adams, H ;

Messing, S ;

Rothberg, PG ;

Levy, E ;

McDonough, T ;

DeYoung, J ;

Wang, M ;

Ramirez-Montealegre, D ;

Kwon, JM ;

Pearce, DA .

NEUROLOGY, 2005, 65 (02) :275-279

[10]

MOLE SE, 2009, NEURONAL CEROID LIPO

← 1 2 →